(Q37856440)

24 August 2017

1 reference

title

Eosinophilic oesophagitis: latest intelligence (English)

1 reference

24 August 2017

A M Schoepfer

1

1 reference

24 August 2017

D Simon

series ordinal

2

1 reference

24 August 2017

A Straumann

series ordinal

3

1 reference

24 August 2017

publication date

24 March 2011

1 reference

Clinical & Experimental Allergy

24 August 2017

published in

1 reference

24 August 2017

volume

41

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

630-639

1 reference

Idiopathic eosinophilic esophagitis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

The differential diagnosis of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

21 January 2018

Eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Clinical and Endoscopic Features of Eosinophilic Esophagitis in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Primary eosinophilic disorders of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Gastrointestinal eosinophils in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Fundamental signals that regulate eosinophil homing to the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eotaxin is required for the baseline level of tissue eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

The role of adhesion molecules in human eosinophil and basophil recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Esophageal remodeling in pediatric eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

An etiological role for aeroallergens and eosinophils in experimental esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

IL-5 promotes eosinophil trafficking to the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Non-surgical interventions for eosinophilic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

The natural history and complications of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03739.X

10.1111/J.1365-2222.2011.03739.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference